Business
Press Release Nov 10 2023
Lupin Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement forRanibizumab Biosimilar.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated November 10, 2023, titled \"Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement forRanibizumab Biosimilar.\". View Attachment","length":365,"tagName":"div"}]